Dr. MADU Anazoeze Jude.

Department: Medicine
Faculty: Medical Sciences
Designation : Senior Lecturer
Email: anazoeze.madu@unn.edu.ng
Phone: +2348037861784


Publications (Articles and Journals):

1.    Madu A J, Ibegbulam O G, Ocheni S, Madu K A, Aguwa E N. Haemogram pattern at diagnosis of malignant disorders and variations post-chemotherapy. Nigerian Journal of Medicine. Vol. 2 (2); June 2011. P 256-60.
2.    Madu A J, Ibegbulam O G, Ocheni S, Madu K A, Aguwa E N. Absolute neutrophil values in Malignant patients on Cytotoxic Chemotherapy. Nigerian Journal of Medicine. Vol.2 (1); March 2011. P 120-4
3    AJ Madu, N Galadanci, U Kangiwa, S U Abdulahi, K Kaladada, Fowodu F, T Lawal, O Ulasi, A Ikefuna, A Duru, B Chukwu, O Okocha, J Orkuma,  MIheanacho, M Inyiama, A Hassan, O Akinpelu, T Nwagha, S Ocheni, O Ibegbulam, I Emodi, U Anike, C Nonyelu, C Anigbo, K Agu, I Ajuba,  A Chukwura, O A Ugwu , U Ololo, AgwuObineche, I Okpala. Stroke Prevalence amongst Sickle Cell Disease patients in Nigeria: A Multi-Centre Study. Africa Health Science. June 2014;14(2): 446-52
4    I Okpala, O Ezenwosu, A Ikefuna, A Duru, B Chukwu, A Madu, T Nwagha, S Ocheni, O Ibegbulam, I Emodi, U Anike, C Nonyelu, C Anigbo, K Agu, I Ajuba,  A Chukwura, O Ugwu  and U Ololo.  Addition of Multimodal Therapy to Standard Management of Steady State Sickle Cell Disease. ISRN Hematology; 2013 (Vol 13), 1-5.
5    Madu A J, Ibegbulam O G, Ocheni S, Madu K A, Aguwa E N. Pattern of CD4 T lymphocyte Values in Cancer patients on Cytotoxic Therapy. Annals of Medical and Health Research. Vol 4 (3);Oct 2013. 498- 503.
6    Okpala I, Ibegbulam O, Duru A, Ocheni S, Emodi I, Ikefuna A, Umar G, Asinobi I, Madu A, Okoye A, Nwagha T, Oguonu U, Uamai I, Agwu O, Nonyelu C, Anike U, Agu K, Anigbo C, Chukwura A, Ugwu O, Herrada S. Pilot study of Omega 3 fatty acids in sickle cell disease. APMIS. 119 (7); July 2011.P 442-8.
7    Madu A J, Ubesie A, Madu K A, Okwor B, Anigbo C. Evaluation of clinical and laboratory correlates of sickle leg ulcers. Wound Regeneration and Repair. Oct 2013. 21; 808-12.
8    A J Madu, AUbesie, S Ocheni, J Chinawa, K A Madu, O G Ibegbulam, C Nonyelu, A Eze. Priapism in Homozygous Sickle Cell Patients: Important Clinical and Laboratory Associations. Medical Principles and Practice. DOI.10.1159/000360608. March 2014;23:259-63
9    Madu A J, Madu K A, Kangiwa U G, Ibekwe K, Duru A N, Ugwu O. Avascular necrosis in sickle cell (homozygous S) patients: Predictive clinical and laboratory indices. Nigerian Journal of Clinical Practice. 2014; 17(1): 86-9.
10    Ubesie A, Madu KA, Madu AJ, Duru A. Musculoskeletal Complications of Sickle cell Anaemia: Findings from South-east Nigeria. International Journal for Tropical diseases and Health. 3(3). May 2013, 175-183.
11    R Anakwue, S Ocheni, A Madu. Utilization of oral anticoagulation in a Teaching hospital in Nigeria. Annals of Medical and Health Research. Vol 4 (3). September/October 2014. P286-90.
12    A J Madu, AUbesie, K Madu, O Ibegbulam, C Nonyelu. Specialist Preferences and Reasons among Fresh Nigerian Interns. Annals of Medical and Health Research. Vol 4 (3). September/October 2014. P 223-7.
13    A J Madu, S Ocheni, T ANwagha, O G Ibegbulam, U S Anike. Multiple Myeloma in Nigeria: An insight into the clinical and laboratory features and outcomes. Nigerian Journal of Clinical Practice. 2014; 17(1): 212-7.
14    Kangiwa U, Ibegbulam O, Ocheni S, Madu A, Ndakosu M. Pattern and prevalence of allo-immunization in multiply transfused patients with sickle cell disease. Biomarker Research. (2015) 3:26. DOI 10.1186/s40364-015-0050-3   
15    Ajuba C, Madu AJ, Okocha C, Ibegbulam OG, Okpala I, Nna O. Frequency and Clinical impact of ETV6/RUNX1, AF4-MLL and BCR/ABL fusion genes on features of Acute Lymphoblastic Leukaemia (ALL) at presentation. Nigerian Journal of Clinical Practice. 2015; DOI 10.4103/1119-3077.164351.
16    Madu A.J, Abuknesha N, Ghebremeskel K. The role of membrane lipids in inflammation: A review of the evolving pathogenesis of sickle cell disease. Biology and Medicine. 2015;7: 244. doi:10.4172/0974-8369.1000244.
17    Madu A, Ibegbulam O, Ocheni S, Chukwura A, Madu K. Comparison of the sensitivity absolute neutrophil to CD4 lymphocyte values as a marker of immunosuppression in cancer patients on cytotoxic chemotherapy. African Health Science. 2015;15(2): 599-607.
18    Madu AJ, Ubesie A, Ocheni S, Chinawa J, Madu KA, Ibegbulam OG, Nlemadim C, Eze A. Important clinical and laboratory correlates of glomerular filtration rate in sickle cell anaemia. Nigerian Journal of Clinical Practice. 2015;18: 633-7.

Research and Training Seminars attended:
CourseOrganizers Date
Practical Biostatistics Course              Safety Biomedicals                              20 – 24 June  2011
Haematology School 2011         Safety Biomedicals& University of Nigeria    21 – 25 Feb 2011         
Blood Transfusion Practice        Safe Blood for Africa &Pepffar (APIN)          Nov 2010
1st Global Congress on Sickle Cell Disease  Childrens Hospital Philadelphia      July 2010
Research Methodology                 National Postgraduate MedicalCollege          August 2008
Health Resource Management      National Postgraduate Medical College          March 2008
Biostatistics Course                      National Postgraduate MedicalCollege           August 2008
Intensive Revision course in        National Postgraduate Medical College           September 2008
Pathology for  Part I & II FMCPath Candidates
Training Workshop in Public Health  Community Medicine College                  August 2006
                    of Medicine University of Nigeria

Papers Presented in International seminars and workshops:
1.Haematology School 2015, Enugu. –Multiple Myeloma: An Update. 11 September 2015. 
2. Haematology School 2014, Enugu. – Cellular Origins and Management of Multiple Myeloma. 4 February 2014. 
3. Nigeria Haemophilia Foundation Conference. Enugu  - Treatment and Prevention of Transfusion Transmissible Infections. 2nd Aug 2014.
4. Haemophilia Foundation of Nigeria (HFN) South East Haemophilia Zone National Medical Training, Enugu - Managing a haemophilic bleed the role of blood products and factor concentrates. November 19, 2013.
5. Haematology School 2013, Enugu - Current concepts in diagnosis and treatment of Multiple myeloma. February 2013.
6. Nigerian Society for Haematology and Blood Transfusion (AGM), Benin -  1.Clinical features and outcomes of Multiple myeloma in Eastern Nigeria 2. Comparison of the sensitivity of absolute neutrophil to CD4 lymphocyte values as a marker of immunosuppression in cancer patients on cytotoxic chemotherapy. September 2013.
7. World Sickle Cell Day (Sickle Cell Association of Nigeria), Abuja. - 1.Evaluation of clinical and laboratory correlates of sickle leg ulcers 2. Avascular necrosis in sickle cell (homozygous S) patients: predictive clinical and laboratory indices. June 2013.
8. Nigerian Haemophilia Foundation. Enugu. -  Management of haemophilic bleed: the role of blood components and factor concentrates. Nov 2013.  
9. Nigeria Medical Association Enugu Sate (AGM) – Haematological Manifestations of HIV. July 2012.

Peer-review of articles for Publication:
I serve as a Peer-reviewer for the following Journals:
1.    Nigerian Journal of Experimental and Clinical Biosciences
2.    African International Surgery
3.    British Journal for Pharmaceutical Research
4.    Tumor Biology
5.    CardioVascular Journal of Africa
6.    Annals of Medical and Health Science Research
7.    British Journal of A subset of genes can distinguish between Bortezomib responsive versus bortezomib resistant myeloma
8.    Nigerian Journal of Medicine
9.    Journal of the Egyptian National Cancer Institute
10.    Nigerian Journal of Experimental and Clinical Biosciences.


More
Area of Specialization
Responsibilities
Working Experience
Biography


https://www.unn.edu.ng/internals/#



Back